This report explores model changes that allowed for clinical trial efficiencies from the perspective of the CRO and is based on a set of workshops with COVID-19 vaccine clinical delivery teams. Our emphasis is on understanding what was possible because of the drastic operating environment changes and assessing what can be carried forward into the post-pandemic clinical development pipeline of therapies for other illnesses.
As more states begin to relax restrictions to reopen local
economies, the need for a quantitative measure of readiness is essential to
make evidence-based decisions. This report features a new Reopening Readiness
Index (RRI) and a Health Services Utilization Index (HSUI) to help guide
decision-making on relaxing COVID-19 restrictions.
This report highlights key shifts in the US healthcare landscape as a result of COVID-19. Focus areas in this report include
COVID-19 has been a dramatic – and traumatic – pressure test of healthcare around the world. As we look to the future, we see 10 areas of healthcare to rethink in order to not only be prepared for future disease outbreaks, but also develop a better, more sustainable approach to human health. This is the first in a series of papers that will look at how Human Data Science can transform how healthcare works.